Search

Focuses on the boundaries between scientific fact and science fiction based from the study conducted in Great Britain. Influence of science fiction on public perception towards biomedical sciences; Comparison among the interpretations of scientists, teachers and students on science; Distinction between lay versus scientific or expert knowledge.

The world of clinical negligence is facing and will continue to face major upheavals in the delivery of justice. The speciality depends on a heady witch's brew of claimants, doctors, experts, lawyers and judiciary, not to mention the political interests of the legislature, the financial interests of the accountants and, finally and most importantly, the moral interests of society. From our jaded perspective of about 40 years joint experience in the medico-legal skin trade we offer the benefits of our wisdom. In the dark moments late at night, answering difficult questions from lawyers, we do understand that 'Medical experts are like sewers - what you get out of them depends on what you put into them' (after Tom Lehrer) but we believe that the ideal instructing lawyer is able to prepare the scene in such a way that we can produce prompt, excellent and clear advice to our legal colleagues. In this article we set out to explore the relationship between medical experts and lawyers by examining the characteristics of the bad lawyer, as it was in the past, is now and might be in the future. [ABSTRACT FROM AUTHOR]

Purpose. Clear cell chondrosarcoma is a rare variant of chondrosarcoma. Six cases are herein reported. Subjects. We have treated six patients with clear cell chondrosarcoma in the past 28 years, representing 1.6% of all chondrosarcomas seen in this time period. Results and Discussion. Half the patients had been initially underdiagnosed and inappropriately treated. Conclusions. Our results and our review of the literature highlight the fact that inadequate initial treatment leads to a high rate of both local recurrence and metastasis whilst wide initial excision is usually curative. [ABSTRACT FROM AUTHOR]

Purpose Paget's osteosarcoma has a fearful reputation with a quoted survival of at best 5% at 5 years. We therefore reviewed our experience of 26 patients treated over the last 25 years using modern staging and limb salvage techniques to see if there had been any improvement in survival. Subjects: We identified 26 patients on the Royal Orthopaedic Hospital Oncological database with a diagnosis of sarcoma secondary to Paget's disease. Results: The survival rate was 53% at 1 year, 25% at 2 years and no patient survived for 5 years. The median survival was 21 months for those treated with curative intent and 7 months for those treated palliatively. Four of the five patients treated with limb-sparing surgery developed local recurrence between 5 and 12 months, the fifth died at 14 months. There was no difference in survival between amputation and limb salvage. Discussion: The development of sarcomatous change in Paget's disease is well recognised. It represents an important segment of primary bone tumours in patients over 40 years of age. The prognosis is appalling. Indeed only 15 of 368 cases (4%) from a number of historical series have survived more than 5 years. Our results are similarly disappointing with no survivors at 5 years despite modern methods of management of bone tumours. While there is no difference in local recurrence rates or survival between limb reconstruction and limb ablation the poor prognosis for both means that neither can be recommended at present. Sarcomatous change in Pagetoid bone should therefore be regarded as a different disease to primary osteosarcoma. It remains an incurable disease with a poor prognosis. [ABSTRACT FROM AUTHOR]